Discount Code (0% Off) has been applied.
 
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item
Manufacturer: Fresenius Kabi

Calcium Gluconate Injection, USP is a sterile, preservative-free solution designed for intravenous use. This essential injection is commonly used to treat acute symptomatic hypocalcemia in both adult and pediatric patients.

 

Key Benefits:

  • Rapid Calcium Replenishment: Efficiently restores calcium levels in patients experiencing acute hypocalcemia.
  • Supports Critical Bodily Functions: Calcium is vital for numerous physiological processes, including muscle contraction and blood coagulation.
  • Sterile and Safe: Manufactured under stringent conditions to ensure a preservative-free, nonpyrogenic solution for safe intravenous use.

 

Dosage and Administration:

This injection is intended for intravenous use and should be administered with caution. Dosage varies based on the severity of hypocalcemia:

  • Adult Patients: Typically 1,000 to 2,000 mg, administered either as a bolus or continuous infusion.
  • Pediatric Patients: 100-200 mg/kg for neonates and 29-60 mg/kg for older children, with regular monitoring of serum calcium levels. The solution must be diluted prior to IV administration and administered slowly to prevent adverse reactions.

 

Why Choose Calcium Gluconate Injection?

  • Versatile Use: Effective in treating hypocalcemia and associated symptoms, such as neuromuscular irritability.
  • Clinically Trusted: Widely used in hospitals and clinical settings for its rapid action in critical care situations.
  • Safe for a Range of Patients: Suitable for pediatric, adult, and geriatric patients, with dose adjustments as necessary.

 

Warnings:

  • Arrhythmias: Use with caution in patients receiving cardiac glycosides, as concurrent use can increase the risk of arrhythmias.
  • Tissue Necrosis: Extravasation can lead to serious complications, including calcinosis cutis and tissue necrosis.
  • Drug Incompatibilities: Do not mix with fluids containing phosphate or bicarbonate. Incompatible with ceftriaxone, especially in neonates.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

Calcium Gluconate 100mgmL SDV 10mL Vial
Calcium Gluconate 100mgmL SDV 10mL Vial
Manufacturer: Fresenius Kabi (Shop the Brand)

Calcium Gluconate Injection 100mg/mL, Single Dose Vial 10 mL, Each

Item Code: 000566
Mfg Part #: 63323-0360-19
$23.99
Requires Verified Medical License to Purchase
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
About This Product

Calcium Gluconate Injection, USP is a sterile, preservative-free solution designed for intravenous use. This essential injection is commonly used to treat acute symptomatic hypocalcemia in both adult and pediatric patients.

 

Key Benefits:

  • Rapid Calcium Replenishment: Efficiently restores calcium levels in patients experiencing acute hypocalcemia.
  • Supports Critical Bodily Functions: Calcium is vital for numerous physiological processes, including muscle contraction and blood coagulation.
  • Sterile and Safe: Manufactured under stringent conditions to ensure a preservative-free, nonpyrogenic solution for safe intravenous use.

 

Dosage and Administration:

This injection is intended for intravenous use and should be administered with caution. Dosage varies based on the severity of hypocalcemia:

  • Adult Patients: Typically 1,000 to 2,000 mg, administered either as a bolus or continuous infusion.
  • Pediatric Patients: 100-200 mg/kg for neonates and 29-60 mg/kg for older children, with regular monitoring of serum calcium levels. The solution must be diluted prior to IV administration and administered slowly to prevent adverse reactions.

 

Why Choose Calcium Gluconate Injection?

  • Versatile Use: Effective in treating hypocalcemia and associated symptoms, such as neuromuscular irritability.
  • Clinically Trusted: Widely used in hospitals and clinical settings for its rapid action in critical care situations.
  • Safe for a Range of Patients: Suitable for pediatric, adult, and geriatric patients, with dose adjustments as necessary.

 

Warnings:

  • Arrhythmias: Use with caution in patients receiving cardiac glycosides, as concurrent use can increase the risk of arrhythmias.
  • Tissue Necrosis: Extravasation can lead to serious complications, including calcinosis cutis and tissue necrosis.
  • Drug Incompatibilities: Do not mix with fluids containing phosphate or bicarbonate. Incompatible with ceftriaxone, especially in neonates.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Calcium Gluconate
Route of Administration Intravenous (IV)
Strength 100 mg/mL
Volume 10 mL
Container Single Dose Vial
Feature Preservative-Free
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68º to 77ºF)
Therapeutic Class Calcium Deficiencies

Calcium Gluconate Injection, USP — 100 mg/mL | 10 mL Single-Dose Vial

Calcium Gluconate Injection, USP is a sterile, preservative-free, nonpyrogenic solution for intravenous use, supplied at a concentration of 100 mg/mL (9.3 mg/0.465 mEq elemental calcium per mL). Indicated for pediatric and adult patients, it is the clinical standard for rapid treatment of acute symptomatic hypocalcemia.

Each 10 mL single-dose vial delivers 1,000 mg of calcium gluconate. The solution must be diluted in 5% dextrose or normal saline prior to administration and used immediately after preparation.

Key Benefits

  • Targeted Hypocalcemia Treatment: Indicated for acute symptomatic hypocalcemia in neonates, pediatric patients, and adults; 100% bioavailable via IV administration.
  • Rapid Ionized Calcium Restoration: Calcium gluconate dissociates directly into ionized calcium in plasma, providing immediate electrolyte correction without hepatic first-pass metabolism.
  • Flexible Dosing Formats: Supports both bolus and continuous IV infusion; dose individualized by symptom severity, serum calcium level, and acuity of onset.
  • Preservative-Free, Single-Dose Safety: Sterile, nonpyrogenic formulation in a single-dose vial eliminates preservative exposure and cross-contamination risk.
  • Established Pediatric and Adult Labeling: FDA-approved (NDA208418) with validated dosing tables for neonates (≤1 month), pediatric patients (>1 month to

Dosage and Administration

For intravenous use only. Dilute prior to administration. Do not administer if particulate matter or discoloration is present. Use diluted solution immediately.

  • Bolus IV Administration: Dilute to 10–50 mg/mL in 5% dextrose or normal saline. Do not exceed 200 mg/minute in adults or 100 mg/minute in pediatric patients. ECG monitoring required.
  • Continuous IV Infusion: Dilute to 5.8–10 mg/mL. Adult initial rate: 5.4–21.5 mg/kg/hour. Pediatric (>1 month to
  • Standard Adult Dose: 1,000–2,000 mg initial bolus; may repeat every 6 hours if needed.
  • Serum Calcium Monitoring: Every 4–6 hours during intermittent infusion; every 1–4 hours during continuous infusion.
  • Renal Impairment: Initiate at lowest recommended dose for all age groups; monitor serum calcium every 4 hours.
  • Geriatric Use: Start at the low end of the dosage range due to higher frequency of renal, hepatic, or cardiac impairment.

Why Choose Calcium Gluconate Injection?

  • When Oral Routes Are Not Viable: IV calcium gluconate provides immediate, controlled electrolyte correction in patients unable to tolerate or absorb oral calcium supplementation.
  • Versatile Clinical Application: Suitable for bolus correction of acute episodes or continuous infusion for sustained calcium management across all age groups.
  • Pharmacy Bulk Package Available: The 10,000 mg/100 mL pharmacy bulk package (PBP) supports high-volume admixture programs within ISO Class 5 environments, with a 4-hour use window post-puncture.

Warnings

  • Cardiac Glycoside Interaction: Concomitant use may produce synergistic arrhythmias. Avoid co-administration; if unavoidable, infuse slowly in small amounts with continuous ECG monitoring.
  • Tissue Necrosis and Calcinosis Cutis: Can occur with or without extravasation. Immediately discontinue infusion at the affected site if calcinosis or extravasation is detected.
  • Ceftriaxone Incompatibility — Contraindicated in Neonates ≤28 Days: Concurrent IV ceftriaxone may form life-threatening precipitates. Fatal outcomes in neonates have been reported. Do not mix or co-administer via Y-site in any age group.

Disclaimer: This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.
Products specifications
Calcium Gluconate Injection 100mgmL Single Dose Vial 10 mL 25Tray
Calcium Gluconate 100mgmL SDV 10mL Vial
Calcium Gluconate 100mgmL SDV 10mL Vial
Manufacturer: Fresenius Kabi (Shop the Brand)

Calcium Gluconate Injection 100mg/mL, Single Dose Vial 10 mL, 25/Tray

Item Code: 009929
Mfg Part #: 63323-0360-19
$539.78
Requires Verified Medical License to Purchase
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
About This Product

Calcium Gluconate Injection, USP is a sterile, preservative-free solution designed for intravenous use. This essential injection is commonly used to treat acute symptomatic hypocalcemia in both adult and pediatric patients.

 

Key Benefits:

  • Rapid Calcium Replenishment: Efficiently restores calcium levels in patients experiencing acute hypocalcemia.
  • Supports Critical Bodily Functions: Calcium is vital for numerous physiological processes, including muscle contraction and blood coagulation.
  • Sterile and Safe: Manufactured under stringent conditions to ensure a preservative-free, nonpyrogenic solution for safe intravenous use.

 

Dosage and Administration:

This injection is intended for intravenous use and should be administered with caution. Dosage varies based on the severity of hypocalcemia:

  • Adult Patients: Typically 1,000 to 2,000 mg, administered either as a bolus or continuous infusion.
  • Pediatric Patients: 100-200 mg/kg for neonates and 29-60 mg/kg for older children, with regular monitoring of serum calcium levels. The solution must be diluted prior to IV administration and administered slowly to prevent adverse reactions.

 

Why Choose Calcium Gluconate Injection?

  • Versatile Use: Effective in treating hypocalcemia and associated symptoms, such as neuromuscular irritability.
  • Clinically Trusted: Widely used in hospitals and clinical settings for its rapid action in critical care situations.
  • Safe for a Range of Patients: Suitable for pediatric, adult, and geriatric patients, with dose adjustments as necessary.

 

Warnings:

  • Arrhythmias: Use with caution in patients receiving cardiac glycosides, as concurrent use can increase the risk of arrhythmias.
  • Tissue Necrosis: Extravasation can lead to serious complications, including calcinosis cutis and tissue necrosis.
  • Drug Incompatibilities: Do not mix with fluids containing phosphate or bicarbonate. Incompatible with ceftriaxone, especially in neonates.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Calcium Gluconate
Route of Administration Intravenous (IV)
Strength 100 mg/mL
Volume 10 mL
Container Single Dose Vial
Feature Preservative-Free
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68º to 77ºF)
Therapeutic Class Calcium Deficiencies

Calcium Gluconate Injection, USP — 100 mg/mL | 10 mL Single-Dose Vial

Calcium Gluconate Injection, USP is a sterile, preservative-free, nonpyrogenic solution for intravenous use, supplied at a concentration of 100 mg/mL (9.3 mg/0.465 mEq elemental calcium per mL). Indicated for pediatric and adult patients, it is the clinical standard for rapid treatment of acute symptomatic hypocalcemia.

Each 10 mL single-dose vial delivers 1,000 mg of calcium gluconate. The solution must be diluted in 5% dextrose or normal saline prior to administration and used immediately after preparation.

Key Benefits

  • Targeted Hypocalcemia Treatment: Indicated for acute symptomatic hypocalcemia in neonates, pediatric patients, and adults; 100% bioavailable via IV administration.
  • Rapid Ionized Calcium Restoration: Calcium gluconate dissociates directly into ionized calcium in plasma, providing immediate electrolyte correction without hepatic first-pass metabolism.
  • Flexible Dosing Formats: Supports both bolus and continuous IV infusion; dose individualized by symptom severity, serum calcium level, and acuity of onset.
  • Preservative-Free, Single-Dose Safety: Sterile, nonpyrogenic formulation in a single-dose vial eliminates preservative exposure and cross-contamination risk.
  • Established Pediatric and Adult Labeling: FDA-approved (NDA208418) with validated dosing tables for neonates (≤1 month), pediatric patients (>1 month to

Dosage and Administration

For intravenous use only. Dilute prior to administration. Do not administer if particulate matter or discoloration is present. Use diluted solution immediately.

  • Bolus IV Administration: Dilute to 10–50 mg/mL in 5% dextrose or normal saline. Do not exceed 200 mg/minute in adults or 100 mg/minute in pediatric patients. ECG monitoring required.
  • Continuous IV Infusion: Dilute to 5.8–10 mg/mL. Adult initial rate: 5.4–21.5 mg/kg/hour. Pediatric (>1 month to
  • Standard Adult Dose: 1,000–2,000 mg initial bolus; may repeat every 6 hours if needed.
  • Serum Calcium Monitoring: Every 4–6 hours during intermittent infusion; every 1–4 hours during continuous infusion.
  • Renal Impairment: Initiate at lowest recommended dose for all age groups; monitor serum calcium every 4 hours.
  • Geriatric Use: Start at the low end of the dosage range due to higher frequency of renal, hepatic, or cardiac impairment.

Why Choose Calcium Gluconate Injection?

  • When Oral Routes Are Not Viable: IV calcium gluconate provides immediate, controlled electrolyte correction in patients unable to tolerate or absorb oral calcium supplementation.
  • Versatile Clinical Application: Suitable for bolus correction of acute episodes or continuous infusion for sustained calcium management across all age groups.
  • Pharmacy Bulk Package Available: The 10,000 mg/100 mL pharmacy bulk package (PBP) supports high-volume admixture programs within ISO Class 5 environments, with a 4-hour use window post-puncture.

Warnings

  • Cardiac Glycoside Interaction: Concomitant use may produce synergistic arrhythmias. Avoid co-administration; if unavoidable, infuse slowly in small amounts with continuous ECG monitoring.
  • Tissue Necrosis and Calcinosis Cutis: Can occur with or without extravasation. Immediately discontinue infusion at the affected site if calcinosis or extravasation is detected.
  • Ceftriaxone Incompatibility — Contraindicated in Neonates ≤28 Days: Concurrent IV ceftriaxone may form life-threatening precipitates. Fatal outcomes in neonates have been reported. Do not mix or co-administer via Y-site in any age group.

Disclaimer: This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.
Products specifications
Brands in this category
Picture for manufacturer American Regent
Picture for manufacturer Exela
Picture for manufacturer Hospira
Picture for manufacturer McGuff Pharmaceuticals
Picture for manufacturer Mylan

Featured Articles

McGuff’s Promise of Quality and Service

For over 50 years, we’ve been the trusted name in healthcare excellence. Medical practitioners can rely on us for quality products, fast deliveries, and superior service. We strive for customer satisfaction and maintaining that trust.

We at the McGuff Company, Inc. (McGuff) work very hard to provide you accurate and timely information on our website. However, it is your obligation to verify such information before using the products purchased from McGuff.

All information is provided “As-is” and may change without prior notice. McGuff does not make warranty or representation that the information contained on this site is accurate, current, or complete.

Any use of information by you is without recourse to McGuff and is at your own risk.

McGuff is in no way responsible for any damages whether direct, consequential, incidental, or otherwise suffered by you or others on your behalf as a result of using or relying upon such information for any purpose.

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Calcium Gluconate
Route of Administration Intravenous (IV)
Strength 100 mg/mL
Volume 10 mL
Container Single Dose Vial
Feature Preservative-Free
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68º to 77ºF)
Therapeutic Class Calcium Deficiencies

Contact Us

McGuff Company is LegitScript Certified

Copyright © 2026 McGuff Company, Inc. All rights reserved.

For information on the duties and responsibilities of this web site, please read our privacy policy and our warning and disclaimer . Use of this website signifies your agreement to the Privacy Policy and Warning Disclaimer.

Coronavirus (COVID-19)

Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.

In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.

Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.

As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.

Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President